← Back to Search

Robotic Exoskeleton for Multiple Sclerosis

N/A
Recruiting
Research Sponsored by Kessler Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up approximately 12 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial will study the effects of a robotic exoskeleton on mobility, learning, and memory in people with MS-related walking disability.

Who is the study for?
This trial is for individuals aged 18-75 with multiple sclerosis who have moderate to severe walking difficulties but can still walk using an exoskeleton. Participants should have cognitive challenges, be stable in their MS treatment for at least a month, and fit the physical requirements for the exoskeleton (height between 60 and 76 inches, weight under 220 lbs).
What is being tested?
The study compares traditional gait therapy to rehabilitation using a wearable robotic exoskeleton called Ekso-GT. It aims to assess improvements in mobility, learning, memory, and walking abilities in people with Multiple Sclerosis.
What are the potential side effects?
Potential side effects are not explicitly listed but may include discomfort or fatigue from wearing the device, skin irritation where it contacts the body, muscle soreness after use, or falls due to imbalance while adjusting to the exoskeleton.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~approximately 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and approximately 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Brain scans
Distance walked in a specific time duration
Neuropsychological measures of thinking

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Robotic Exoskeleton TherapyExperimental Treatment1 Intervention
Gait rehabilitation provided using a wearable robotic exoskeleton
Group II: Conventional Gait TherapyActive Control1 Intervention
Gait rehabilitation provided using traditional gait therapy under the supervision of a licensed PT

Find a Location

Who is running the clinical trial?

Kessler Institute for RehabilitationIndustry Sponsor
22 Previous Clinical Trials
1,155 Total Patients Enrolled
Kessler FoundationLead Sponsor
182 Previous Clinical Trials
11,083 Total Patients Enrolled
~1 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top